Reserpine modulates neurotransmitter release to extend lifespan and alleviate age-dependent Aβ proteotoxicity in Caenorhabditis elegans

Experimental Gerontology

Volumn 47, Issue 2, 2012, Pages 188-197

  Saharia, Kopal ^a   Arya, Upasna ^a   Kumar, Ranjeet ^a   Sahu, Rashmi ^a   Das, Chinmaya Kumar ^a   Gupta, Kuldeep ^a   Dwivedi, Hemalata ^a   Subramaniam, Jamuna R ^a  

^a INDIAN INSTITUTE OF TECHNOLOGY KANPUR   (India)

Author keywords

Acetylcholine; Alzheimer's disease; Amyloid beta toxicity; C. elegans; Lifespan extension; Reserpine

Indexed keywords

ACETYLCHOLINE; ALDICARB; AMYLOID BETA PROTEIN; DOPAMINE; LEVAMISOLE; RESERPINE; SEROTONIN;

ACETYLCHOLINE RELEASE; ALZHEIMER DISEASE; ARTICLE; CAENORHABDITIS ELEGANS; CONTROLLED STUDY; DISEASE MODEL; DRUG INDUCED DISEASE; DRUG MECHANISM; GENETIC STRAIN; LIFE EXTENSION; MUTANT; NONHUMAN; PARALYSIS; PRESYNAPTIC NERVE; PRIORITY JOURNAL; REGULATORY MECHANISM;

ACETYLCHOLINE; AGING; ALDICARB; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ANIMALS; ANTIHYPERTENSIVE AGENTS; CAENORHABDITIS ELEGANS; CHOLINESTERASE INHIBITORS; LONGEVITY; NEUROTRANSMITTER AGENTS; RESERPINE; VESICULAR MONOAMINE TRANSPORT PROTEINS;

CAENORHABDITIS ELEGANS;

EID: 84856225429     PISSN: 05315565     EISSN: 18736815     Source Type: Journal    
DOI: 10.1016/j.exger.2011.12.006     Document Type: Article

References (53)

1. Ailion M., Inoue T., Weaver C.I., Holdcraft R.W., Thomas J.H. Neurosecretory control of aging in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 1999, 96:7394-7397.
2. Alfonso A., Grundahl K., Duerr J.S., Han H.P., Rand J.B. The Caenorhabditis elegans unc-17 gene: a putative vesicular acetylcholine transporter. Science 1993, 261(5121):617-619.
3. Arya U., Dwivedi H., Subramaniam J.R. Reserpine ameliorates Abeta toxicity in the Alzheimer's disease model in C. elegans. Exp. Gerontol. 2009, 44(6-7):462-466.
4. Brenner S. The genetics of Caenorhabditis elegans. Genetics 1974, 77:71-94.
5. Bruijn L.I., Miller T., Cleveland D.W. Unraveling the mechanisms involved in motor neuron degeneration in ALS. Annu. Rev. Neurosci. 2004, 27:723-749.
6. Cohen E., Bieschke J., Perciavalle R.M., Kelly J.W., Dillin A. Opposing activities protect against age-onset proteotoxicity. Science 2006, 313:1604-1610.
7. Culetto E., Baylis H.A., Richmond J.E., Jones A.K., Fleming J.T., Squire M.D., Lewis J.A., Sattelle D.B. The Caenorhabditis elegans unc-63 gene encodes a levamisole-sensitive nicotinic acetylcholine receptor alpha subunit. J. Biol. Chem. 2004, 279(41):42476-42483.
8. Dempsey M.C., Mackenzie M.S., Gargus A., Blanco G., Sze J.Y. Serotonin (5HT), fluoxetine, imipramine and dopamine target distinct 5HT receptor signaling to modulate Caenorhabditis elegans egg-laying behavior. Genetics 2005, 169:1425-1436.
9. Duerr J.S., Frisby D.L., Gaskin J., Duke A., Asermely K., Huddleston D., Eiden L.E., Rand J.B. The cat-1 gene of Caenorhabditis elegans encodes a vesicular monoamine transporter required for specific monoamine-dependent behaviours. J. Neurosci. 1999, 19:72-84.
10. Friedman D.B., Johnson T.E. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics 1988, 118:75-86.
11. Garcia S.M., Casanueva M.O., Silva M.C., Amaral M.D., Morimoto R.I. Neuronal signaling modulates protein homeostasis in Caenorhabditis elegans post-synaptic muscle cells. Genes Dev. 2007, 21:3006-3016.
12. Gunawardena S., Her L.S., Brusch R.G., Laymon R.A., Niesman I.R., Gordesky-Gold B., Sintasath L., Bonini N.M., Goldstein L.S. Disruption of axonal transport by loss of Huntington or expression of pathogenic polyQ proteins in Drosophila. Neuron 2003, 40(1):25-40.
13. Hall D.H., Hedgecock E.M. Kinesin-related gene unc-104 is required for axonal transport of synaptic vesicles in C. elegans. Cell 1991, 65(5):837-847.
14. Henderson S.T., Johnson T.E. daf-16 integrates developmental and environmental inputs to mediate aging in the nematode Caenorhabditis elegans. Curr. Biol. 2001, 11:1975-1980.
15. Hsu A.L., Murphy C.T., Kenyon C. Regulation of aging and age-related disease by DAF-16 and heat-shock factor. Science 2003, 300:1142-1145.
16. Huang C., Xiong C., Kornfeld K. Measurements of age-related changes of physiological processes that predict lifespan of Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:8084-8089.
17. Kenyon C. The genetics of aging. Nature 2010, 464:504-512.
18. Kenyon C., Chang J., Gensch E., Rudner A., Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature 1993, 366:461-464.
19. Keowkase, et al. Neuroprotective effects and mechanism of cognitive-enhancing choline analogs JWB 1-84-1 and JAY 2-22-33 in neuronal culture and Caenorhabditis elegans. Mol. Neurodegener. 2010, 5:59.
20. Kimura K.D., Tissenbaum H.A., Liu Y., Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science 1997, 277:942-946.
21. Kopito R.R., Ron D. Conformational Disease. Nat. Cell Biol. 2000, 2:E207-E209.
22. Lakowski B., Hekimi S. The genetics of caloric restriction in Caenorhabditis elegans. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:13091-13096.
23. Lele R.D. Beyond reverse pharmacology: Mechanism-based screening of Ayurvedic drugs. J. Ayurveda Integr. Med. 2010, 1(4):257-265. 2010 Oct.
24. Lewis J.A., Wu C.H., Berg H., Levine J.H. The genetics of levamisole resistance in the nematode Caenorhabditis elegans. Genetics 1980, 9(5):905-928.
25. Libina N., Berman J.R., Kenyon C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell 2003, 15(4):489-502.
26. Lin K., Dorman J.B., Rodan A., Kenyon C. daf-16: An HNF-3/forkhead Family Member That Can Function to Double the Life-Span of Caenorhabditis elegans. Science 1997, 278:1319-1322.
27. Link C.D. Expression of human-amyloid peptide in transgenic Caenorhabditis elegans. Proc. Natl. Acad. Sci. 1995, 92:9368-9372.
28. Liu Q., Zhang J., Zhu H., Qin C., Chen Q., Zhao B. Dissecting the signaling pathway of nicotine-mediated neuroprotection in a mouse Alzheimer disease model. FASEB J. 2007, 21:61-73.
29. Loer C.M., Kenyon C.J. Serotonin-deficient mutants and male mating behavior in the nematode Caenorhabditis elegans. J. Neurosci. 1993, 13(12):5407-5417.
30. Mahoney T.R., Luo S., Nonet M.L. Analysis of synaptic transmission in Caenorhabditis elegans using an aldicarb-sensitivity assay. Nat. Protoc. 2006, 4:1772-1777.
31. Minghetti L., Ajmone-Cat M.A., Berardinis M.A.D., Simone R.D. Microglial activation in chronic neurodegenerative diseases: roles of apoptotic neurons and chronic stimulation. Brain Res. Rev. 2005, 48(2):251-256.
32. Murakami H., Murakami S. Serotonin receptors antagonistically modulate C. elegans longevity. Aging Cell 2007, 6:483-488.
33. Nguyen M., Alfonso A., Johnson C.D., Rand J.B. Caenorhabditis elegans mutants resistant to inhibitors of acetylcholinesterase. Genetics 1995, 140:527-535.
34. Opperman C.H., Chang S. Effects of aldicarb and fenamiphos on acetycholinesterase and motility of Caenorhabditis elegans. J. Nematol. 1991, 23(1):20-27.
35. Petrascheck M., Ye X., Buck L.B. An antidepressant that extends lifespan in adult Caenorhabditis elegans. Nature 2007, 450:553-556.
36. Rand J.B., Russell R.L. Choline acetyltransferase-deficient mutants of the nematode Caenorhabditis elegans. Genetics 1984, 106(2):227-248.
37. Rand J.B., Russell R.L. Molecular basis of drug-resistance mutations in C. elegans. Psychopharmacol. Bull. 1985, 21(3):623-630.
38. Rebolledo D.L., Aldunate R., Kohn R., Neira I., Minniti A.N., Inestrosa N.C. Copper reduces Aβ oligomeric species and ameliorates neuromuscular synaptic defects in a C. elegans model of inclusion body myositis. J. Neurosci. 2011, 31:10149-10158.
39. Saifee O., Wei L., Nonet M.L. The Caenorhabditis elegans unc-64 locus encodes a syntaxin that interacts genetically with synaptobrevin. Mol. Biol. Cell 1998, 9(6):1235-1252.
40. Sambrook Russell Molecular Cloning-A Laboratory manual. 1.831-1.884 2001.
41. Selkoe D.J. Abeta aggregates review. Nature 2003, 426:900.
42. Simon D.J., Madison J.M., Conery A.L., Thompson-Peer K.L., Soskis M., Ruvkun G.B., Kaplan J.M., Kim J.K. The microRNA miR-1 regulates a MEF-2-dependent retrograde signal at neuromuscular junctions. Cell 2008, 133:903-915.
43. Steinkraus K.A., Smith E.D., Davis C., Carr D., Pendergrass W.R., Sutphin G.L., Kennedy B.K., Kaeberlein M. Dietary restriction suppresses proteotoxicity and enhances longevity by an hsf-1-dependent mechanism in Caenorhabditis elegans. Aging Cell 2008, 7(3):394-404.
44. Srivastava D., Arya U., SoundaraRajan T., Dwivedi H., Kumar S., Subramaniam J.R. Reserpine can confer stress tolerance and lifespan extension in the nematode C. elegans. Biogerontology 2008, 9:309-316.
45. Sulston J., Dew M., Brenner S. Dopaminergic neurons in the nematode Caenorhabditis elegans. J. Comp. Neurol. 1975, 163(2):215-226.
46. Tabet N. Acetylcholinesterase inhibitors for Alzheimer's disease: anti-inflammatories in acetylcholine clothing!. Age Ageing 2006, 35:336-338.
47. Touroutine D., Fox R.M., Von Stetina S.E., Burdina A., Miller D.M., Richmond J.E. acr-16 encodes an essential subunit of the levamisole-resistant nicotinic receptor at the Caenorhabditis elegans neuromuscular junction. J. Biol. Chem. 2005, 280:27013-27021.
48. Trushina E., McMurray C.T. Oxidative stress and mitochondrial dysfunction in neurodegenerative diseases. Neuroscience 2007, 145(4):1233-1248.
49. Vakil R.J. A clinical trial of rauwolfia serpentine in essential hypertension. Br. Hear. J. 1949, 11(4):350-355.
50. Wang Z.W., Saifee O., Nonet M.L., Salkoff L. SLO-1 potassium channels control quantal content of neurotransmitter release at the C. elegans neuromuscular junction. Neuron 2001, 32(5):867-881.
51. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., Sinclair D. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
52. Wu Y., Luo Y. Transgenic C. elegans as a Model in Alzheimer's Research. Curr. Alzheimer Res. 2005, 2:37-45.
53. Zhang Y., Champagne N., Beitel L.K., Goodyer C.G., Trifiro M., LeBlanc A. Estrogen and androgen protection of human neurons against intracellular amyloid _1-42 toxicity through heatshock protein 70. J. Neurosci. 2004, 24(23):5315-5321.